Beta blockers inhibit which adrenergic receptor subtypes?

Prepare for the Essentials for Oral Sedation Monitoring Test. Use flashcards, multiple-choice questions, hints, and explanations to enhance your readiness. Get fully equipped for your exam with comprehensive preparation!

Multiple Choice

Beta blockers inhibit which adrenergic receptor subtypes?

Explanation:
Beta blockers act as antagonists at beta-adrenergic receptors, preventing catecholamines from activating them. They primarily affect two subtypes: Beta-1, which are mainly in the heart and kidneys, and Beta-2, found in smooth muscle of the lungs and vasculature, as well as in liver and skeletal muscle. Because the drug class targets these beta receptors, it can inhibit both Beta-1 and Beta-2—though some agents are selective for Beta-1 only, while others are nonselective and block both. Alpha receptors (Alpha-1 and Alpha-2) are not targeted by beta blockers, which is why the relevant receptor subtypes are Beta-1 and Beta-2.

Beta blockers act as antagonists at beta-adrenergic receptors, preventing catecholamines from activating them. They primarily affect two subtypes: Beta-1, which are mainly in the heart and kidneys, and Beta-2, found in smooth muscle of the lungs and vasculature, as well as in liver and skeletal muscle. Because the drug class targets these beta receptors, it can inhibit both Beta-1 and Beta-2—though some agents are selective for Beta-1 only, while others are nonselective and block both. Alpha receptors (Alpha-1 and Alpha-2) are not targeted by beta blockers, which is why the relevant receptor subtypes are Beta-1 and Beta-2.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy